Insider: Gheuens Sarah Chief Medical Officer - AGIOS PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 67,608 | 0 | 67,608 |
| Value | $2,311,517.52 | $0.00 | $2,311,517.52 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/02/2026 | DDS | 1,187 | Direct | COM | $28.96 | $34,375.52 | 67,608 |
| 03/02/2026 | DDS | 1,681 | Direct | COM | $28.96 | $48,681.76 | 71,593 |
| 03/02/2026 | DDS | 1,187 | Direct | COM | $28.96 | $34,375.52 | 74,406 |
| 12/30/2025 | DDS | 2,932 | Direct | COM | $27.09 | $79,427.88 | 64,795 |
| 11/11/2025 | DDS | 2,454 | Direct | COM | $43.78 | $107,436.12 | 61,727 |
| 10/30/2025 | DDS | 200 | Direct | COM | $43.81 | $8,762.00 | 61,727 |
| 10/27/2025 | DDS | 3,302 | Direct | COM | $43.92 | $145,023.84 | 61,727 |
| 07/09/2025 | DDS | 11,067 | Direct | COM | $37.93 | $419,771.31 | 62,118 |
| 07/09/2025 | DDS | 847 | Direct | COM | $38.76 | $32,829.72 | 61,271 |
| 07/01/2025 | DDS | 4,091 | Direct | COM | $34.17 | $139,789.47 | 61,271 |
| 06/24/2025 | DDS | 2,909 | Direct | COM | $33.54 | $97,567.86 | 56,988 |
| 03/03/2025 | DDS | 1,681 | Direct | COM | $35.54 | $59,742.74 | 53,897 |
| 03/03/2025 | DDS | 1,137 | Direct | COM | $35.54 | $40,408.98 | 47,098 |
| 03/03/2025 | DDS | 1,187 | Direct | COM | $35.54 | $42,185.98 | 49,911 |
| 07/01/2024 | DDS | 3,705 | Direct | COM | $43.85 | $162,464.25 | 43,736 |
| 03/05/2024 | DDS | 1,293 | Direct | COM | $32.57 | $42,113.01 | 36,415 |
| 03/05/2024 | DDS | 1,349 | Direct | COM | $32.57 | $43,936.93 | 39,066 |
| 02/14/2024 | DDS | 642 | Direct | COM | $25.14 | $16,139.88 | 33,431 |
| 01/24/2024 | DDS | 1,708 | Direct | COM | $21.64 | $36,961.12 | 31,911 |
| 01/09/2024 | DDS | 1,789 | Direct | COM | $22.99 | $41,129.11 | 27,869 |
| 06/30/2023 | DDS | 1,707 | Direct | COM | $28.36 | $48,410.52 | 24,159 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research